PROFITABLE DNA NUTRITION PLATFORM, 10,000 USERS

Business Overview:

PROFITABLE DNA NUTRITION PLATFORM, 10,000 USERS, 59% SDE MARGIN

A profitable, founder-built precision-nutrition platform that has sold its core product every day for eight years.

The company translates a customer's DNA into a practical, personalized way of eating. A proprietary algorithm classifies each customer into one of twenty named diet types, then generates a personalized meal plan and nutrition protocol built around how that individual actually metabolizes fat, carbohydrate, protein, caffeine, histamine, and dietary cholesterol. On top of that core sits a growing library of premium health reports — cardiovascular, methylation, micronutrient, longevity, sleep, and more — sold as an annual membership currently held by approximately 1,000 members, plus a branded supplement line matched to the genetic results.

This is a product with demonstrated durable product-market fit. It launched in 2018, has served thousands of customers, and has generated revenue continuously since. The twenty-diet-type framework is what customers connect with, talk about, and return for: an identity and a plan rather than a raw data dump. Customer acquisition runs on SEO, organic search, email, and word of mouth, supported by HSA/FSA eligibility and inbound demand from clinics and integrative-medicine practitioners.

The business is profitable and capital efficient. Revenue grew from under $60,000 to $555,300 in three years while remaining profitable every year. In 2025 it generated $327,200 in seller's discretionary earnings — a 59% SDE margin — on a fully remote operation with no full-time employees and approximately 79% gross margins.

The platform has also proven it can extend. A 2025 supplement line and a 2026 environmental-genomics release were both built and shipped on modest budgets using the existing architecture, and a consented research cohort has been accumulating alongside the core business. These represent optionality on top of a proven cash-generating core.

Highlights:

• $555,300 revenue in 2025 | $327,200 SDE | ~79% gross margins
• Eight consecutive years of sales on the core DNA nutrition product, launched 2018
• ~110% three-year revenue CAGR (FY22 $58.5K → FY25 $555.3K); SDE up from $29.9K to $327.2K
• Proprietary twenty-diet-type taxonomy built on 200+ vetted genetic factors, each carrying an internal Science Grade derived from a two-year peer-reviewed literature review
• AI engine generating personalized meal plans and nutrition protocols directly from genetic results
• Approximately 1,000 members paying annual fees — an established subscription layer built without a dedicated conversion program
• Two acquisition paths into the core product: physical test kits fulfilled through a CLIA-certified lab, and near-zero-COGS analysis of raw data uploaded from 23andMe and Ancestry
• 2025 supplement line with repeat-purchase behavior
• Demonstrated B2B demand from wellness clinics, IV clinics, functional-medicine providers, and physicians
• Strong SEO, low CAC, HSA/FSA eligible
• Lean and remote: owner part-time plus four independent contractors, no physical overhead
• Consented, transferable genome + environment research dataset — a monetization path not yet activated

Contact the Seller:

To request more information regarding this listing, simply check the ADD TO REQUEST INFO BASKET button (above Quick Facts) and when you are done searching and have made all your selections, simply click on the REQUEST FREE INFO button at the bottom of this page.

Property Features and Assets:

The company was built science-first. Before launch, the founding team — led by a head of research and lead geneticist — spent the better part of two years reviewing hundreds of peer-reviewed studies on genetics and nutrition, ranking genes by scientific validation and assigning each an internal Science Grade. That research became the backbone of the nutrition algorithm and the twenty-diet-type framework.
The product launched in 2018 anchored on a central scientific question: why do people respond so differently to the same foods — for example, large versus negligible LDL changes on the same saturated-fat intake? Eight years later, that question still drives the roadmap. The company has since layered a premium health-report membership, a supplement line, and an environmental-genomics module onto the same core platform, each reusing the existing infrastructure rather than requiring a rebuild.

Market Competition and Expansion:

Expand the supplement line and complete the Amazon marketplace launch. The core analysis already tells every customer which supplements matter for them; the fulfillment of that recommendation is currently mostly unmonetized. This is the seller's view of the nearest-term opportunity.
• Push the raw-data upload channel. Millions of consumers hold 23andMe and Ancestry data with no ongoing use for it. This channel carries near-zero COGS and is undermarketed.
• Formalize the B2B channel. Demand from clinics, functional-medicine practices, universities, and sports teams is already arriving inbound. No structured partner program, pricing tier, or practitioner dashboard exists yet.
• Add reports to the membership library. Each new report increases the value of the existing ~1,000-member base with no change to acquisition cost. The architecture is purpose-built for this.
• Deepen the membership base. Roughly 1,000 of ~10,000 registered users currently subscribe, achieved without a dedicated conversion program. A buyer with lifecycle-marketing capability has clear headroom here.
• Activate data licensing. The consent framework already permits commercial research partnerships — an untapped, high-margin revenue line.
• Press the environmental-genomics position if the buyer's strategy favors it — differentiated and largely uncontested.
• International and partnership expansion, leveraging a high-margin digital delivery model.
• Market tailwind: the personalized nutrition and nutrigenomics market is projected to grow at a 17.4% compound annual rate through 2030 (Grand View Research).

Business is positioned well to be a serious competitor in the space.

Eight years of proven demand, not a launch story. The core product has sold continuously since 2018 and has personalized nutrition for thousands of customers. This is not a business asking a buyer to underwrite an unproven thesis — the demand is established, measured, and repeatable.
A framework customers actually love. The twenty diet types give an abstract genetic result a name, a personality, and a meal plan. That is why the product retains attention in a category where most competitors deliver a PDF the customer reads once. It supports word-of-mouth acquisition, repeat purchase into the membership tier, and a low blended customer acquisition cost.
Profitable and growing — rare in consumer genomics. Most companies in this category burn cash. This one has compounded revenue and earnings together to a 59% SDE margin while fully self-funded.
An established recurring layer. Approximately 1,000 customers hold paid annual memberships to the premium health report library, accumulated organically at the point of analysis rather than through a dedicated conversion campaign. A buyer inherits this layer rather than having to build it.
Earnings understate true owner’s cash flow. Roughly $293,300 has been invested in product development throughout the company's life, expensed as incurred and largely elective. The platform costs very little to simply operate. A new owner can convert that spending into cash flow or keep compounding growth. (See "The Earnings Story.")
A real technology and data asset, not a reseller. The value sits in a proprietary nutrition algorithm and diet-type taxonomy, an AI protocol engine, a library of premium health reports, and a consented research dataset — all owned, all transferable.

Reason for Selling:

Other Personal Interests. Kindly ask the seller for more information.

Additional Details:

Relevant Links:

• View more Wyoming businesses for sale
• View more Businesses For Sale in the same industry
• Sell a business online
• Find a business broker